ID   GM05756
AC   CVCL_7436
SY   GM5756; GM 5756; GM5756A
DR   CLO; CLO_0024666
DR   Coriell; GM05756
DR   Wikidata; Q54841931
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
RX   PubMed=3745952;
RX   PubMed=17668376;
RX   PubMed=33038742;
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   CelloPub=CLPUB00720;
RA   Greene A.E., Mulivor R.A.;
RT   "1986/1987 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 13th edition. October 1986.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 87-2011; pp.1-549; National Institutes of Health; Bethesda (1986).
//
RX   PubMed=2705456;
RA   Weiss M.J., Ray K., Fallon M.D., Whyte M.P., Fedde K.N.,
RA   Lafferty M.A., Mulivor R.A., Harris H.;
RT   "Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and
RT   enzymatic activity in cultured skin fibroblasts from 14 unrelated
RT   patients with severe hypophosphatasia.";
RL   Am. J. Hum. Genet. 44:686-694(1989).
//
RX   PubMed=3745952; DOI=10.1111/1523-1747.ep12285424;
RA   Sephel G.C., Davidson J.M.;
RT   "Elastin production in human skin fibroblast cultures and its decline
RT   with age.";
RL   J. Invest. Dermatol. 86:279-285(1986).
//
RX   PubMed=17668376; DOI=10.1086/519248;
RA   Prandini P., Deutsch S., Lyle R., Gagnebin M., Delucinge-Vivier C.,
RA   Delorenzi M., Gehrig C., Descombes P., Sherman S.L.,
RA   Dagna-Bricarelli F., Baldo C., Novelli A., Dallapiccola B.,
RA   Antonarakis S.E.;
RT   "Natural gene-expression variation in Down syndrome modulates the
RT   outcome of gene-dosage imbalance.";
RL   Am. J. Hum. Genet. 81:252-263(2007).
//
RX   PubMed=33038742; DOI=10.1016/j.scr.2020.102011;
RA   Xu X.-G., Pradhan M., Xu M., Cheng Y.-S., Beers J.K., Linask K.L.,
RA   Lin Y.-S., Zheng W., Zou J.-H.;
RT   "Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D,
RT   TRNDi024-D and TRNDi025-A) generated from fibroblasts of four healthy
RT   individuals.";
RL   Stem Cell Res. 49:102011-102011(2020).
//